In collaboration with Scientific Association of Iranian Medicinal Plants

Document Type : Research Paper

Authors

1 Basic Sciences Department, Isfahan Cardiovascular Research Center, Applied physiology research center, Isfahan University of Medical Sciences, Iran

2 Department of Biology, Faculty of Science, Isfahan University, Iran

3 Department of Pathology, Faculty of Medicine, Isfahan University of Medical Sciences, Iran

Abstract

In this study, anti atherosclerosis effect of aerial parts extract of Amaranthus caudatus L. on rabbits was studied. Twenty male New Zealand rabbits were randomly divided into four groups of five and were fed for 60 days as follows: standard diet, standard diet and cholesterol, standard diet and Amaranthus caudatus extract (150 mg/kg daily), standard diet and Amaranthus caudatus extract (150 mg/kg daily) and cholesterol. Prior to the beginning of diets and at the 60th day of experiment, the biochemical factors were measured. The fatty streak formation was evaluated at the end of the study. Rabbits fed high cholesterol diet with Amaranthus Caudatus extract cholesterol, LDL-C, triglyceride, apo-lipoprotein B (apoB), CRP, atherogenic index (AI) significantly decreased and HDL-C and apo-lipoprotein A (apoA) increased compared to with high cholesterol group. Also lesion severity, in extract recipient group, significantly decreased. Amaranthus caudatus extract by decreasing serum lipoproteins and apo B, is one of the most important new risk factors of cardiovascular diseases and by decreasing inflammatory factors prevent atherosclerosis.

Keywords

- زرگری، ع. 1375. گیاهان دارویی. جلد اول، انتشارات و چاپ دانشگاه تهران، 432 صفحه.
- Ahaneku, J.E., Nwosu, C.M. and Farotimi, A., 2001. Lipid and lipoprotein cardiovascular risk factor responses to episodic academic stress. Journal of Health Science, 47, 3: 323-326.
- Andrea, Y.A. and Plate, J.A.G., 2002. Cholesterol-lowering effect of extruded amaranth (Amaranthus caudatus L.). Food Chemistry, 76: 1-6.
- Borradaile, N.M., Dreu, L.E., Barrett, P.H.R. and Huff, M.W., 2002. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradtion independent of reduced microsomal cholesteryl esters. Journal of Lipid Research, 43:1544-1554.
- Bhatia, A.L. and Jain, M., 2003. Amaranthus paniculatus (Lim.) improves learning after radiation stress. Journal of Ethnopharmacology, 85: 73-79.
- Chekanov, V.S., 2003. Low frequency electrical impulses reduce atherosclerosis in cholesterol fed rabbits. Medical science monitor, 9(8): 302-309.
- Danz, R.A. and Lupton, J.R., 1992. Physiology effects of dietary amaranth (Amaranthus cruentus) on rats. Cereal Foods World, 37(7): 489-494.
- Erdemoglu, N., Kupeli, E. and Yesilada, E., 2003. Anti-inflammatory and antinociceptive assessment of plants used as remedy in Turkish folk medicine. Journal of Ethnopharmacology, 89: 123 – 129.
- Grundy, S.M., Pasternak, R. and Greenland, P., 1999. Assessment of cardiovascular risk by use of multiple-risk professionals from the AmericanCollege of Cardiology. Journal of the AmericanCollege of Cardiology, 34: 1348-59.
- Parmley, W.W., 1997. Nonlipoprotein risk factors for coronary heart disease: evaluation and management. American Journal of Medicine, 102: 7-14.
- Pergola, C., Rossi, A., Dugo, P., Cuzzocrea, S. and Sautebin, L., 2006. Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Biology and Chemistry, 15: 30-39.
- Qureshi, A.A., Qureshi, N., Wright, J.J.K., Shen, Z., Kramer, G., Gapor, A., Chong, Y.H. and Bradlow, B.A., 1991. Lowering of serum cholesterol in hyperchlesterolemic humans by tocotrienols (palmvitee). American Journal of Clinical Nutrition, 53:1021-1026.
- Rasouli, M., Kiasari. M.A. and Mokhberi, V., 2006. The ratio apoB/apoA, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clinical Chemistry and Laboratory Medicine, 44(8): 1015-1021.
- Thakur, N., Hayashi, T. and Iguchi, A., 2001. HMG-COA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxidase. American Journal Physiology, 281: 75-83.
- Walldius, G. and Jungner, I., 2004. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine, 255:188-205.
- Walldius, G., Jungner, I., Holme, I., Aastveit, A.H., Kolar, W. and Steiner, E., 2001. High apolipoprotein B, low apolipoprotein A-I and improvement in the prediction of fatal myocardial infarction: aprospective study. Lancet, 358: 2026-2033.
- Yusuf, S., Hawken, S., Ounpuu, S., Dans, T. and Avezum, A., 2004. Effect of potentially modifiable risk factors assoiated with myocardial infarction in 52 countries: case control study. Lancet, 364: 937-952.
- Zou, Y., Lu, Y. and Wei, D., 2005. Hypercholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet. Journal of Agricultural and Food Chemistry, 53: 2462-2466